TONI-ANN WILLIAMS: Open Payments
NPI 1033813852 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 78 payments from 15 companies in 2025. Trend: 2023 $678 · 2024 $1,231 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $255 |
| Corium, LLC | 10 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $156 |
| Neurocrine BioSciences, Inc. | 7 | $143 |
| Lundbeck LLC | 5 | $104 |
| Teva Pharmaceuticals USA, Inc. | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Tris Pharma Inc | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
Products named: VRAYLAR, Azstarys, CAPLYTA, REXULTI, INGREZZA, AUSTEDO XR, Auvelity, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
